ReviewJournal of clinical and diagnostic research : JCDR2017
Analysis of Survival Data: Challenges and Algorithm-Based Model Selection.
Review in Journal of clinical and diagnostic research : JCDR, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Racial and ethnic differences in time to shock delivery in out-of-hospital cardiac arrest.Resuscitation plus · 2026Article
- Opioids in Critically Ill Acute Myocardial Infarction Patients: A Retrospective Analysis of the MIMIC-IV Database.Journal of general internal medicine · 2025Article
- Comparative real-world survival of first-line atezolizumab, nivolumab, and pembrolizumab in older patients with metastatic non-small cell lung cancer.Journal of managed care & specialty pharmacy · 2025Article
- Analysis of recurrent events in cluster randomised trials: The PLEASANT trial case study.Statistical methods in medical research · 2025Article
- Evaluating key predictors of breast cancer through survival: a comparison of AFT frailty models with LASSO, ridge, and elastic net regularization.BMC cancer · 2025Article
- Constructing and identifying an eighteen-gene tumor microenvironment prognostic model for non-small cell lung cancer.World journal of surgical oncology · 2024Article
- A non-randomized controlled trial to assess the protective effect of SMC in the context of high parasite resistance in Uganda.Malaria journal · 2023Article
- A multistate transition model for statin-induced myopathy and statin discontinuation.CPT: pharmacometrics & systems pharmacology · 2021Article
- Early life exposure to tobacco smoke and ovarian cancer risk in adulthood.International journal of epidemiology · 2021Article
- RNA m6A Methylation Regulators Multi-Omics Analysis in Prostate Cancer.Frontiers in genetics · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Survival data is a special form of time to event data that is often encountered while modelling risk. The classical Cox proportional hazard model, that is popularly used to analyse survival data, cannot be used for modelling risk when the proportional hazard assumption is violated or when there is recurrent time to event data. In this context we conducted this narrative review to develop an algorithm for selection of advanced methods of analysing survival data in the above-mentioned situations. Findings were synthesized from literature retrieved from searches of Pubmed, Embase, and Google Scholar. Existing literature suggest that for non-proportionality, especially due to categorical predictors stratified Cox model may be useful. An accelerated failure time model is applicable in case of different follow-up time among different experimental groups and the median time to event is the outcome of interest instead of hazard. Extended Cox models and marginal models are used in case of multivariate ordered failure events and the type of model depends upon the presence of clustering and nature of ordering. In the presence of heterogeneity, a shared frailty model is used that is analogous to mixed models. More advanced models, including competing risk and multistate models are required for modelling competing risk, multiple states and multiple transitions. Joint models are used for multiple time dependent outcomes with different attributes. We have developed an algorithm based on the review for appropriate model selection to curb the challenge of modeling survival data and the algorithm is expected to help the naïve researchers in analysing survival data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.